Showing results (81-90 of 181) with videos related to
Sort By:
Pageof 19
BMC Medicine|March 2, 2018
Adaptive designs in clinical trials: why use them, and how to run and report themPhilip Pallmann, Alun W Bedding, Babak Choodari-Oskooei, et al.Acta Oto-Laryngologica|March 20, 2019
3 T - MRI improves intrameatal cranial nerve detection in CI-candidatesHerbert Stimmer, Hans-Peter Niedermeyer, Lynne Stecher, et al.Biostatistics (Oxford, England)|August 22, 2022
Bayesian sample size determination in basket trials borrowing information between subsetsHaiyan Zheng, Michael J Grayling, Pavel Mozgunov, et al.Frontiers in Medicine|October 31, 2022
Design and analysis of umbrella trials: Where do we stand?Luke O Ouma, James M S Wason, Haiyan Zheng, et al.Drug Discovery Today|August 4, 2024
Multidisciplinary considerations for implementing Bayesian borrowing in basket trialsKristine R Broglio, Jenny E Blau, Elizabeth A Pilling, et al.Statistics in Medicine|April 2, 2023
Online error rate control for platform trialsDavid S Robertson, James M S Wason, Franz König, et al.BMC Medical Research Methodology|June 13, 2026
The predictive power of first recruits to commercial trial performanceMartin J Batty, James M S Wason, David J Ward, et al.JCO Precision Oncology|January 5, 2024
Handling Incomplete or Late-Onset Toxicities in Early-Phase Dose-Finding Clinical Trials: Current Practice and Future ProspectsZhulin Yin, Adrian P Mander, Johann S de Bono, et al.BMC Cancer|January 27, 2022
Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trialsMichael J Grayling, Martina McMenamin, Robert Chandler, et al.Frontiers in Endocrinology|October 9, 2018
Associations Between C-Reactive Protein, Insulin Sensitivity, and Resting Metabolic Rate in Adults: A Mediator AnalysisTheresa Drabsch, Christina Holzapfel, Lynne Stecher, et al.Pageof 19